Professional
Added to YB: 2025-07-03
Pitch date: 2025-06-30
MURA [neutral]
Mural Oncology plc
-17.41%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.
Market Cap
$36.1M
Pitch Price
$2.47
Price Target
3.25 (+59%)
Dividend
N/A
EV/EBITDA
0.21
P/E
-0.30
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Clark Street Value Mid Year 2025 Portfolio Review: Current Position - Mural Oncology plc
MURA (holding update): All development halted, seeking strategic alternatives. Est. liquidation value $3.25/share vs $2.50 current price. Comments suggest acquisition/reverse merger more likely than liquidation due to spin-off safe harbor expiry (Nov) and Irish takeover rules.
Read full article (1 min)